Health Care & Life Sciences » Pharmaceuticals | Jilin Zixin Pharmaceutical Industrial Co. Ltd.

Jilin Zixin Pharmaceutical Industrial Co. Ltd. | Mutual Funds

Mutual Funds that own Jilin Zixin Pharmaceutical Industrial Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Nanfang CSI 500 ETF
2,231,022
0.17%
-84,900
0.09%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
833,200
0.07%
0
0%
07/31/2018
609,095
0.05%
453,495
0.63%
12/31/2016
310,516
0.02%
28,100
0.19%
12/31/2017
GF CSI 500 ETF
174,878
0.01%
-38,100
0.09%
12/31/2017
Harvest CSI 500 ETF
120,200
0.01%
-3,500
0.08%
12/31/2017
117,802
0.01%
12,800
0.28%
12/31/2017
102,900
0.01%
-4,700
0.09%
12/31/2017
65,104
0.01%
-10,000
0.08%
12/31/2017
53,748
0%
-7,100
0.67%
12/31/2017

About Jilin Zixin Pharmaceutical Industrial Co.

View Profile
Address
No. 137 Dongtoudao Street
Changchun Jilin 130041
China
Employees -
Website http://www.jilinzixin.com.cn
Updated 07/08/2019
Jilin Zixin Pharmaceutical Industrial Co., Ltd. engages in the research, development, manufacture, and sale of herbal medicines. Its medicine offers treatment for cardiovascular and cerebrovascular diseases, digestive system diseases, and bone fracture. The company was founded on May 25, 1998 and is headquartered in Changchun, China.